Skip to main content

Animations

MJFF Publications

7781 - 7790 of 8808 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2021
  • 2022
  • 2021
  • 2022
  • 2021
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s disease
    Journal Name: Biomedicine & Pharmacotherapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.biopha.2022.113908
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Home-based transcranial static magnetic field stimulation of the motor cortex for treating levodopa-induced dyskinesias in Parkinson's disease: A randomized controlled trial
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.brs.2022.05.012
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson’s disease and cognition
    Journal Name: Brain, Behavior, and Immunity
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.bbi.2022.01.005
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Protective Factors That Maintain Asymptomatic Longevity in Untreated Congenitally Corrected Transposition of Great Arteries
    Journal Name: CJC Open
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.cjco.2021.11.004
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Mitochondrial hyperfusion via metabolic sensing of regulatory amino acids
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2022.111198
    Citation Count: 28
  • Summary Details
    RESTRICTED
    Title: The Human Tic Detector: An automatic approach to tic characterization using wearable sensors
    Journal Name: Clinical Neurophysiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.clinph.2021.10.017
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Intermuscular coherence as a biomarker of subthalamic nucleus deep brain stimulation efficacy in Parkinson’s disease
    Journal Name: Clinical Neurophysiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.clinph.2022.07.489
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Change in the Parkinson Anxiety Scale correlates with change in other clinical measures of anxiety over time
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100126
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Agglomerative and divisive hierarchical Bayesian clustering
    Journal Name: Computational Statistics & Data Analysis
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.csda.2022.107566
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Distinct atrophy of septal nuclei in Parkinson’s disease
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100171
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.